It was during her early medical training in New Delhi that Dr. Pooja Gupta was first exposed to the amazing experience of childbirth. It was this experience, along with her later entry into motherhood, that formed the foundation of Dr. Gupta’s love for obstetrics. She combined this pursuit with an interest in gynecology and now cares for patients at El Camino Women’s Medical Group.
Dr. Gupta notes that women sometimes neglect their own health while they care for others. One of Dr. Gupta’s goals is to bring healthcare to the caretakers – the mothers, daughters, grandmothers, sisters, and aunts of the world.
Dr. Gupta has received extensive experience and training in India and the United States in high-risk pregnancies. She stands ready to help women in the Mountain View CA area with their obstetric and gynecologic needs.
Dr. Gupta is a member of these professional societies:
- American Board of Obstetrics & Gynecology
- American College of Obstetrics & Gynecology
- American Medical Women’s Association
- California Medical Association
- North American Menopause Society
- Santa Clara Medical Association
In 2011, Dr. Gupta received an award for academic excellence during her residency.
Areas of Interest
Dr. Gupta possesses a particular interest in pregnancy management (both low and high risk), treatment and counseling for infertility, and minimally invasive gynecologic surgery.
English and Hindi
California law requires disclosure of the following information:
HEALTH CARE PRACTITIONER INFORMATION
Name and license: Pooja Gupta, A137156
Highest level of academic degree: Medical Doctor (MD)
Board certification: BOARD CERTIFIED (American Board of Obstetrics & Gynecology)
Hospital affiliations: El Camino Hospital, Mountain View, California
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.